Overview
Pericardial fluid is the fluid present within the pericardial cavity between the visceral and parietal layers of the pericardium. It is an ultrafiltrate of plasma and is normally present in small amounts, usually between 10 and 60 mL. This fluid reduces friction between the heart and surrounding structures, allowing smooth cardiac movements during each heartbeat. Pericardial fluid examination becomes clinically significant when there is excessive accumulation, known as pericardial effusion, which can impair cardiac function and lead to life-threatening complications such as cardiac tamponade.
Symptoms
Patients with pericardial fluid accumulation may present with chest pain or a feeling of chest pressure, which is often relieved by sitting forward. Shortness of breath, orthopnea, and fatigue are common, especially when fluid accumulation interferes with cardiac filling. Clinical examination may reveal muffled heart sounds and raised jugular venous pressure. In severe cases, rapid fluid accumulation can lead to hypotension, pulsus paradoxus, and features of cardiac tamponade.
Causes
Pericardial effusion occurs due to an imbalance between fluid formation and absorption. Infectious causes include tuberculosis, viral infections, bacterial, and fungal pericarditis. Non-infectious causes include malignancies such as lung and breast cancer, lymphomas, autoimmune diseases like systemic lupus erythematosus and rheumatoid arthritis, metabolic disorders such as uremia and hypothyroidism, and post-myocardial infarction states. Trauma, cardiac surgery, aortic dissection, radiation, and certain drugs can also lead to pericardial fluid accumulation.
Risk Factors
Risk factors for pericardial effusion include chronic kidney disease, autoimmune disorders, malignancy, immunosuppression, prior cardiac surgery, chest trauma, and exposure to tuberculosis. Patients with hypothyroidism, liver disease, or hypoalbuminemia are also at increased risk. Rapid accumulation of even a small volume of fluid poses a higher risk of tamponade compared to slow, gradual accumulation.
Prevention
Prevention of pericardial fluid–related complications focuses on early detection and management of underlying conditions. Prompt treatment of infections, adequate control of autoimmune and metabolic disorders, and careful monitoring of high-risk patients reduce morbidity. Timely pericardiocentesis and appropriate laboratory examination of pericardial fluid help identify the cause and guide targeted therapy, preventing progression to cardiac tamponade and improving clinical outcomes.
